Also: anti-VEGF spokeswomen in diabetic macular edema
Researchers winnowed the amount of for the nonce at formerly pediatric ophthalmologists fritter away expending electronic compose records (EHRs) and when that documentation palms come about.
In a point-counterpoint, two wizards wrangle whether the anti-vascular endothelial occurrence factor bevacizumab (Avastin) is effective for treating diabetic macular edema approached to ranibizumab (Lucentis) and aflibercept (Eylea).
Where are we with optical coherence tomography seals for pediatric neuro-ophthalmology? R. Michael Siatkowski, MD, involves his insights on the technology.
One surgeon discusses advances in the small-incision lenticule horses for treating myopia and myopic astigmatism.
This weekly the facts roundup is created to our readers by our consorts at Ophthalmology Intervals, which is a breaking up of UBM Medica. (Self-ruling registration is phoney.)